- Home
- ELME vs RCKT Comparison
ELME vs RCKT Comparison
Compare ELME & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- RCKT
- Stock Information
- Founded
- ELME 1960
- RCKT 1999
- Country
- ELME United States
- RCKT United States
- Employees
- ELME N/A
- RCKT N/A
- Industry
- ELME Real Estate Investment Trusts
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ELME Real Estate
- RCKT Health Care
- Exchange
- ELME Nasdaq
- RCKT Nasdaq
- Market Cap
- ELME 1.3B
- RCKT 1.3B
- IPO Year
- ELME N/A
- RCKT N/A
- Fundamental
- Price
- ELME $15.08
- RCKT $12.56
- Analyst Decision
- ELME Hold
- RCKT Strong Buy
- Analyst Count
- ELME 5
- RCKT 11
- Target Price
- ELME $17.50
- RCKT $50.27
- AVG Volume (30 Days)
- ELME 694.1K
- RCKT 1.7M
- Earning Date
- ELME 02-13-2025
- RCKT 02-24-2025
- Dividend Yield
- ELME 4.77%
- RCKT N/A
- EPS Growth
- ELME N/A
- RCKT N/A
- EPS
- ELME N/A
- RCKT N/A
- Revenue
- ELME $239,523,000.00
- RCKT N/A
- Revenue This Year
- ELME N/A
- RCKT N/A
- Revenue Next Year
- ELME $2.78
- RCKT $233,736.97
- P/E Ratio
- ELME N/A
- RCKT N/A
- Revenue Growth
- ELME 6.62
- RCKT N/A
- 52 Week Low
- ELME $12.74
- RCKT $11.15
- 52 Week High
- ELME $18.49
- RCKT $31.47
- Technical
- Relative Strength Index (RSI)
- ELME 35.87
- RCKT 45.99
- Support Level
- ELME $14.61
- RCKT $11.56
- Resistance Level
- ELME $15.29
- RCKT $13.35
- Average True Range (ATR)
- ELME 0.37
- RCKT 0.65
- MACD
- ELME -0.02
- RCKT 0.22
- Stochastic Oscillator
- ELME 26.00
- RCKT 64.09
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.